Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 10, 2023, after the close
10-Q filed Aug 10, 2023, 41 days after period end · 0000950170-23-041459
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $2.50K |
| Net Income | -$3.39M | -$2.34M | -$31.75M | -$1.85M |
| EPS Diluted | -$7.93 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$5.77 |
| -$4.10 |
| -$0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
